-8.3% · 90d
$92.48
+0.99 (+1.08%)
News
(1)April 2026
Mirum (MIRM) shareholders vote on leadership, auditors, and executive compensation
MIRMMirum Pharmaceuticals, Inc.
# 🧾 What This Document Is This is a **DEF 14A**, or "Proxy Statement." Think of it as an invitation and a voter's guide for Mirum Pharmaceuticals' upcoming annual shareholder meeting. It explains what will be voted on, provides details about the company's leadership and pay, and gives you the tools
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%